Novartis Buys Excellergy for $2B, Anthropic Vs. Pentagon, The Mansion Section | Diet TBPN
TBPN Podcast Recap
Published:
Duration: 32 min
Summary
This episode covers Novartis' $2 billion acquisition of Excellergy, emphasizing its strategic significance in the pharmaceutical industry. It also discusses Anthropic's legal battle with the Pentagon and real estate anecdotes related to JFK's favorite New York hotel.
What Happened
Novartis, a leading Swiss pharmaceutical company valued at $300 billion, has acquired Excellergy for $2 billion. Excellergy, which had been working in stealth mode for five years, was founded with the goal of developing an improved allergy drug targeting the immune molecule IGE. The acquisition includes both an upfront payment and milestone-based payments, highlighting Novartis' strategy to enhance its allergy drug portfolio.
AI technology plays a crucial role in the pharmaceutical industry, as seen with companies like Novo Nordisk Pharma using AI to optimize FDA documentation processes. AI agents are increasingly reducing the time required for clinical trials. Excellergy, backed by Redtree Venture Capital and Samsara Biocapital, had dosed its first Phase 1 patients in February 2026.
Anthropic is advancing its AI model development with the new Mythos model, part of the Capybara series, known for its enhanced capabilities. Despite not being ready for general release, the model is more expensive to run and priced at $0.005 per second. Anthropic faces legal challenges with the Pentagon over supply chain risk designations but has secured a preliminary injunction.
Speculation surrounds Anthropic's potential IPO, which could raise $60 billion as early as Q4. Meanwhile, OpenAI has surpassed a $100 million annualized run rate with its pilot program. In a related development, Apple plans to open Siri to third-party AI assistants, exemplifying the expanding integration of AI technologies.
Real estate stories include Barry Diller's purchase of JFK's favorite New York penthouse for $11 million. The hotel, known for its iconic venues like Bemelon's Bar and Carlisle Cabaret, has a storied history with the Kennedy family, including a direct phone line for JFK in his regular suite.
Homeowners are investing in custom bars within their residences, exemplified by Brian Healy's $800,000 bar area in his Lake Tahoe vacation home. This trend reflects a desire for personalized relaxation spaces, particularly in properties near desirable recreational locations.
In a notable exchange, Mark Zuckerberg texted Elon Musk about Dogecoin progress and offered assistance in managing content issues related to Musk's team. Musk responded positively and inquired about Zuckerberg's interest in bidding on OpenAI intellectual property.
Matthew Zeitlin provided commentary on the antitrust implications of such communications between influential tech figures. This highlights ongoing concerns about the power dynamics and regulatory scrutiny in the tech industry.
Key Insights
- Novartis' $2 billion acquisition of Excellergy underscores the importance of strategic expansions in the pharmaceutical industry, especially concerning allergy treatments targeting immune molecules like IGE.
- AI technologies are significantly impacting drug development processes, with notable companies like Novo Nordisk Pharma employing AI to streamline FDA documentation and reduce clinical trial durations.
- Anthropic's development of the Mythos AI model in the Capybara series reflects ongoing advancements in AI capabilities, despite the model's operational costs and legal challenges with the Pentagon.
- The real estate market sees unique investments like Barry Diller's purchase of a historically significant penthouse and Brian Healy's custom bar, illustrating trends in luxury living and personalized home features.